1. AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea. (12th June 2018) Authors: Iannone, F.; Caporali, R.; Grosso, V.; Favalli, E.G.; Marchesoni, A.; D'Angelo, S.; Tramontano, G.; Sarzi-Puttini, P.; Atzeni, F.; Conti, F.; Miranda, F.; Foti, R.; Amato, G.; Carletto, A.; dal Forno, I.; Gremese, E.; Fedele, A.L.; Cauli, A.; Perra, D.; Ramonda, R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0304 Clinical and serological response to tocilizumab in patients with rheumatoid arthritis. (23rd January 2014) Authors: Casu, C.; Bruschi, E.; Alpini, C.; Marceglia, S.; Giacomelli, L.; Epis, O. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0797 Impairment of coronary microcirculation in patients with diffuse systemic sclerosis. (23rd January 2014) Authors: Atzeni, F.; Gianturco, L.; Sarzi-Puttini, P.; Ricci, C.; Tommasoni, L.; De Gennaro Colonna, V.; Ferrario, P.; Epis, O.; Turiel, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0143 Influence of low-dose glucocorticoid treatment on persistence on biologic dmards therapy: real-life data from the italian gisea registry. (12th June 2018) Authors: Codullo, V.; Manfredi, A.; Lapadula, G.; Gremese, E.; Bortoluzzi, A.; Favalli, E.G.; Gorla, R.; Salaffi, F.; Fusaro, E.; Foti, R.; Cantarini, L.; Cauli, A.; Cantatore, F.P.; Carletto, A.; Conti, F.; D'Angelo, S.; Epis, O.; Ramonda, R.; Atzeni, F.; Sarzi-Puttini, P.C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry. (12th June 2018) Authors: Sebastiani, M.; Manfredi, A.; Iannone, F.; Gremese, E.; Bortoluzzi, A.; Favalli, E. G.; Gorla, R.; Salaffi, F.; Fusaro, E.; Foti, R.; Cantarini, L.; Caporali, R.; Cauli, A.; Alivernini, S.; Cantatore, F. P.; Carletto, A.; Conti, F.; D'Angelo, S.; Epis, O.; Cassone, G. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0223 Predictive factors of early failure to first line treatment with methotrexate in patients with rheumatoid arthritis. results from the gisea registry. (12th June 2018) Authors: Manfredi, A.; Sebastiani, M.; Iannone, F.; Gremese, E.; Bortoluzzi, A.; Favalli, E. G.; Gorla, R.; Salaffi, F.; Fusaro, E.; Foti, R.; Cantarini, L.; Caporali, R.; Cauli, A.; Alivernini, S.; Cantatore, F. P.; Carletto, A.; Conti, F.; D'Angelo, S.; Epis, O.; Ramonda, R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗